Cardiovascular Research Center International Symposium - October 25, 2013
Wednesday, October 23, 2013
This week the University of Iowa Cardiovascular Research Center (CVC) will bring together more than 200 leaders from government, industry and academia from across the nation and around the world for Iowa's first-ever symposium to address the future of scientific research.
Read the agenda here.
Featured Guest Speakers
Rui-Ping Xiao, MD, PhD
Rui-Ping Xiao was trained as a cardiologist and physiologist at Tong-Ji Medical University in Wuhan, China and the Medical School at University of Maryland at Baltimore (UMAB), where she earned her MD in 1984 and PhD in 1995, respectively. She joined the Laboratory of Cardiovascular Science, National Institute of Aging, in 1990 as a postdoctoral fellow, and later in 1996 became a tenure-track investigator and the head of the Receptor Signaling Unit. In 2003, she became Senior Investigator at National Institute of Health, USA. In April 2010, she resigned from NIH and started her career at the Institute of Molecular Medicine, Peking University, Beijing, China. Her main scientific focus has been G-protein coupled receptor (GPCR) signaling in the cardiovascular system.
Patrick Most, MD
Patrick Most is head of the Laboratory for cardiac stem cell and gene therapy at the University of Heidelberg in Germany and Assistant Professor of Medicine and head of the Laboratory for cardiac stem cell and gene therapy at the Center for Translational Medicine at Thomas Jefferson University. His lab focuses on the discovery, development and clinical translation of novel targets for heart failure (HF) therapy. HF, the disability of the cardiac muscle to provide sufficient circulatory support at rest and exercise, currently has limited treatment options and patients suffering from severe HF (NYHA III/IV) face a 5-year mortality > 50%.
For more information about the CVC, take a look at the digital magazine